| NET LOSS PER SHARE |
Net
loss per share is computed using the weighted average number of shares of Common Stock outstanding less the number of shares subject
to repurchase.
The
following table sets forth the computation of basic and diluted net loss per share for the periods indicated (in thousands, except share
data):
| Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three
Months Ended
June 30,
|
|
|
Six
Months Ended
June 30,
|
|
| |
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
| Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
| Net
loss |
|
$ |
(33,607 |
) |
|
$ |
(21,017 |
) |
|
$ |
(54,496 |
) |
|
$ |
(50,755 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator
- basic and diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted
average common shares outstanding |
|
|
74,582,992 |
|
|
|
72,335,952 |
|
|
|
74,528,668 |
|
|
|
72,335,952 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net
loss per share - basic and diluted |
|
$ |
(0.45 |
) |
|
$ |
(0.29 |
) |
|
$ |
(0.73 |
) |
|
$ |
(0.70 |
) |
The
following table sets forth the amounts excluded from the computation of diluted net loss per share as of June 30, 2023 and 2022
because their effect was anti-dilutive.
| Schedule of anti-dilutive net loss per share |
|
|
|
|
|
|
|
|
| |
|
June 30, |
|
| |
|
2023 |
|
|
2022 |
|
| Stock
options outstanding |
|
|
7,766,234 |
|
|
|
7,983,614 |
|
| Non-vested
shares of restricted stock |
|
|
4,510,551 |
|
|
|
6,759,150 |
|
| Warrants(a) |
|
|
27,057,040 |
|
|
|
21,145,000 |
|
| Convertible
notes(a) |
|
|
9,729,163 |
|
|
|
9,729,163 |
|
|
(a) |
The
Convertible Notes and warrants referred to in Notes 11 and 14 were also excluded on an as converted basis because their effect would
have been anti-dilutive. |
|